BrightPath Biotherapeutics Co., Ltd.
A clinical-stage biopharma company developing cancer immunotherapies and cell therapies.
4594 | T
Overview
Corporate Details
- ISIN(s):
- JP3274140007
- LEI:
- Country:
- Japan
- Address:
- 川崎市川崎区殿町三丁目２５番２２号
- Sector:
- Manufacturing
Description
BrightPath Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing novel cancer immunotherapies. The company's core technology is its iPS-NKT platform, a novel allogeneic cell therapy that utilizes induced pluripotent stem cells (iPSCs) to produce large, homogeneous quantities of natural killer T (NKT) cells for cancer treatment. This proprietary approach is designed to overcome the natural scarcity of NKT cells, enabling the therapeutic application of their multifaceted anti-tumor effects. In addition to its cell therapy program, the company's development pipeline includes cancer peptide vaccines and immuno-modulating antibodies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-06-25 06:46 |
内部統制報告書－第18期(令和2年4月1日－令和3年3月31日)
|
Japanese | 23.3 KB | ||
| 2021-06-25 06:45 |
有価証券報告書－第18期(令和2年4月1日－令和3年3月31日)
|
Japanese | 1.8 MB | ||
| 2021-02-12 07:04 |
四半期報告書－第18期第3四半期(令和2年10月1日－令和2年12月31日)
|
Japanese | 158.3 KB | ||
| 2020-11-13 07:01 |
四半期報告書－第18期第2四半期(令和2年7月1日－令和2年9月30日)
|
Japanese | 188.5 KB | ||
| 2020-08-14 08:01 |
四半期報告書－第18期第1四半期(令和2年4月1日－令和2年6月30日)
|
Japanese | 194.9 KB | ||
| 2020-06-29 08:00 |
有価証券報告書－第17期(平成31年4月1日－令和2年3月31日)
|
Japanese | 2.0 MB | ||
| 2020-02-14 07:15 |
四半期報告書－第17期第3四半期(令和1年10月1日－令和1年12月31日)
|
Japanese | 142.8 KB | ||
| 2019-11-08 07:17 |
四半期報告書－第17期第2四半期(2019/07/01－2019/09/30)
|
Japanese | 165.4 KB | ||
| 2019-08-09 08:02 |
四半期報告書－第17期第1四半期(2019/04/01－2019/06/30)
|
Japanese | 132.8 KB | ||
| 2019-06-20 09:42 |
有価証券報告書－第16期(平成30年4月1日－平成31年3月31日)
|
Japanese | 1.5 MB | ||
| 2019-02-14 07:03 |
四半期報告書－第16期第3四半期(2018/10/01－2018/12/31)
|
Japanese | 164.4 KB | ||
| 2018-11-09 07:02 |
四半期報告書－第16期第2四半期(2018/07/01－2018/09/30)
|
Japanese | 188.0 KB | ||
| 2018-08-10 08:49 |
四半期報告書－第16期第1四半期(2018/04/01－2018/06/30)
|
Japanese | 155.8 KB | ||
| 2018-06-21 08:31 |
有価証券報告書－第15期(平成29年4月1日－平成30年3月31日)
|
Japanese | 1.7 MB | ||
| 2018-02-14 07:06 |
四半期報告書－第15期第3四半期(2017/10/01－2017/12/31)
|
Japanese | 196.8 KB |
Automate Your Workflow. Get a real-time feed of all BrightPath Biotherapeutics Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BrightPath Biotherapeutics Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BrightPath Biotherapeutics Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
